SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-019248
Filing Date
2022-05-16
Accepted
2022-05-16 07:50:44
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10037101_10q.htm   iXBRL 10-Q 771959
2 EXHIBIT 31.1 brhc10037101_ex31-1.htm EX-31.1 12373
3 EXHIBIT 31.2 brhc10037101_ex31-2.htm EX-31.2 12393
4 EXHIBIT 32.1 brhc10037101_ex32-1.htm EX-32.1 5860
5 EXHIBIT 32.2 brhc10037101_ex32-2.htm EX-32.2 5896
  Complete submission text file 0001140361-22-019248.txt   4428031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20220331.xsd EX-101.SCH 36142
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20220331_cal.xml EX-101.CAL 33296
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20220331_def.xml EX-101.DEF 187869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20220331_lab.xml EX-101.LAB 498800
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20220331_pre.xml EX-101.PRE 312771
50 EXTRACTED XBRL INSTANCE DOCUMENT brhc10037101_10q_htm.xml XML 565153
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 22925549
SIC: 2834 Pharmaceutical Preparations